Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $42,192 | $24,414 | $58,658 | $204,263 |
| - Cash | $57,263 | $80,927 | $178,266 | $305,744 |
| + Debt | $75,960 | $88,592 | $127,344 | $74,977 |
| Enterprise Value | $60,889 | $32,079 | $7,736 | -$26,505 |
| Revenue | $57,675 | $84,513 | $75,743 | $68,791 |
| % Growth | -31.8% | 11.6% | 10.1% | – |
| Gross Profit | $36,796 | $61,620 | $44,968 | $36,707 |
| % Margin | 63.8% | 72.9% | 59.4% | 53.4% |
| EBITDA | -$104,491 | -$135,721 | -$193,694 | -$146,168 |
| % Margin | -181.2% | -160.6% | -255.7% | -212.5% |
| Net Income | -$45,997 | -$60,637 | -$86,575 | -$64,703 |
| % Margin | -79.8% | -71.7% | -114.3% | -94.1% |
| EPS Diluted | -2.69 | -8.47 | -14.55 | -11.85 |
| % Growth | 68.2% | 41.8% | -22.8% | – |
| Operating Cash Flow | -$80,191 | -$128,225 | -$179,401 | -$116,540 |
| Capital Expenditures | -$15,000 | -$8,098 | -$3,055 | -$16,346 |
| Free Cash Flow | -$95,191 | -$136,323 | -$182,456 | -$132,886 |